| Selective BET Protein Inhibition with Apabetalone and Cardiovascular Events: A Pooled Analysis of Trials in Patients with Coronary Artery Disease |
24 |
| Management of Statin Intolerance in 2018: Still More Questions Than Answers |
23 |
| Clinical Pharmacokinetics, Safety, and Tolerability of a Novel, First-in-Class TRPV4 Ion Channel Inhibitor, GSK279 in Healthy and Heart Failure Subjects |
23 |
| A Meta-Analysis of the Effect of PCSK9-Monoclonal Antibodies on Circulating Lipoprotein (a) Levels |
14 |
| Cardioprotection by Metformin: Beneficial Effects Beyond Glucose Reduction |
13 |
| The Effect of Bromodomain and Extra-Terminal Inhibitor Apabetalone on Attenuated Coronary Atherosclerotic Plaque: Insights from the ASSURE Trial |
11 |
| Clinical Use of Digitalis: A State of the Art Review |
10 |
| Pulmonary Arterial Hypertension: Combination Therapy in Practice |
9 |
| A Systematic Review on the Protective Effect of N-Acetyl Cysteine Against Diabetes-Associated Cardiovascular Complications |
9 |
| Targeting the Prostacyclin Pathway with Selexipag in Patients with Pulmonary Arterial Hypertension Receiving Double Combination Therapy: Insights from the Randomized Controlled GRIPHON Study |
9 |
| Benefit-Risk Assessment of Crataegus Extract WS 1442: An Evidence-Based Review |
8 |
| Adenosine and the Cardiovascular System |
8 |
| Real-World Data of Prasugrel vs. Ticagrelor in Acute Myocardial Infarction: Results from the RENAMI Registry |
7 |
| Macitentan in Pulmonary Arterial Hypertension: A Focus on Combination Therapy in the SERAPHIN Trial |
6 |
| Efficacy and Safety of Dual Blockade of the Renin-Angiotensin-Aldosterone System in Diabetic Kidney Disease: A Meta-Analysis |
6 |
| Ivabradine for the Treatment of Postural Orthostatic Tachycardia Syndrome: A Systematic Review |
5 |
| Patients' Priorities for Oral Anticoagulation Therapy in Non-valvular Atrial Fibrillation: a Multi-criteria Decision Analysis |
5 |
| Clinical Performance of Apixaban vs. Vitamin K Antagonists in Patients with Atrial Fibrillation Undergoing Direct Electrical Current Cardioversion: A Prospective Propensity Score-Matched Cohort Study |
5 |
| Stable but Progressive Nature of Heart Failure: Considerations for Primary Care Physicians |
5 |
| Idarucizumab for Reversal of Dabigatran: Single-Center Real-World Experience |
4 |
| FDA Approval of Angiotensin II for the Treatment of Hypotension in Adults with Distributive Shock |
4 |
| Statin Use and Gastrointestinal Hemorrhage: A Large Retrospective Cohort Study |
4 |
| Patient Characteristics and Real-World Treatment Patterns Among Early Users of PCSK9 Inhibitors |
4 |
| Efficacy and Safety of Intravenous Tenecteplase Bolus in Acute Ischemic Stroke: Results of Two Open-Label, Multicenter Trials |
4 |
| Safety and Prognostic Impact of Early Treatment with Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers in Patients with Acute Heart Failure |
4 |
| Effect of Oral Branched-Chain Amino Acids on Serum Albumin Concentration in Heart Failure Patients with Hypoalbuminemia: Results of a Preliminary Study |
4 |
| How Might Bromodomain and Extra-Terminal (BET) Inhibitors Operate in Cardiovascular Disease? |
4 |
| Morphine and Ticagrelor Interaction in Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction: ATLANTIC-Morphine |
4 |
| Biomarkers of Thrombosis in ST-Segment Elevation Myocardial Infarction: A Substudy of the ATOLL Trial Comparing Enoxaparin Versus Unfractionated Heparin |
4 |
| Rivaroxaban With or Without Aspirin for the Secondary Prevention of Cardiovascular Disease: Clinical Implications of the COMPASS Trial |
4 |
| Prasugrel vs. Ticagrelor for Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis |
4 |
| A Database Cohort Study to Assess the Risk of Angioedema Among Patients with Heart Failure Initiating Angiotensin-converting Enzyme Inhibitors in the USA |
3 |
| Pharmacotherapy of Obesity: Limits and Perspectives |
3 |
| Efficacy and Safety of Incremental Dosing of a New Single-Pill Formulation of Perindopril and Amlodipine in the Management of Hypertension |
3 |
| Trends in Hospital Visits for Generic and Brand-Name Warfarin Users in Quebec, Canada: A Population-Based Time Series Analysis |
3 |
| Efficacy and Safety of Ticagrelor Compared with Clopidogrel in Patients with End-Stage Renal Disease with Acute Myocardial Infarction |
3 |
| The Effects of Clarithromycin on the Pharmacokinetics of Apixaban in Healthy Volunteers: A Single-Sequence Crossover Study |
3 |
| Association Between High-Dose Spironolactone and Decongestion in Patients with Acute Heart Failure: An Observational Retrospective Study |
3 |
| Cost-Effectiveness Analysis of Sacubitril-Valsartan Compared with Enalapril in Patients with Heart Failure with Reduced Ejection Fraction in Thailand |
3 |
| Comparative Efficacy of Drugs for Preventing Acute Kidney Injury after Cardiac Surgery: A Network Meta-Analysis |
3 |
| DAPT Plus Cilostazol is Better Than Traditional DAPT or Aspirin Plus Ticagrelor as Elective PCI for Intermediate-to-Highly Complex Cases: Prospective, Randomized, PRU-Based Study in Taiwan |
3 |
| Efficacy and Safety of the Use of Non-vitamin K Antagonist Oral Anticoagulants in Patients with Ischemic Heart Disease: A Meta-Analysis of Phase III Randomized Trials |
2 |
| Does Coenzyme Q10 Supplementation Mitigate Statin-Associated Muscle Symptoms? Pharmacological and Methodological Considerations |
2 |
| Ivabradine in Postural Orthostatic Tachycardia Syndrome: Preliminary Experience in Children |
2 |
| Atrial Fibrillation in Patients with Heart Failure: Current State and Future Directions |
2 |
| Review of Direct Oral Anticoagulants and Guide for Effective Drug Utilization |
2 |
| Assessment and Management of Patients with Hyperlipidemia Referred for Initiation of PCSK9 Inhibitor Therapy: A Lipid Clinic Experience |
2 |
| A Literature Review of Genetic Markers Conferring Impaired Response to Cardiovascular Drugs |
2 |
| Self-Reported Non-adherence to Medication in Japanese Patients with Cardiovascular Diseases |
2 |
| Association of Beta-Blockers with Survival on Patients Presenting with ACS Treated with PCI: A Propensity Score Analysis from the BleeMACS Registry |
2 |
